Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Alphyn Capital Management Samer Hakoura | “I sold OCSL after management had to admit three new non-accruals, including a 50% write-down on investment in Pluralsight alongside smaller hits at AT Holdings and Dialyze. Those impairments reduced the net asset value and demonstrated that an almost 80% first-lien book can still experience credit pressure, leaving earnings flat and my expected risk-adjusted return below the hurdle I set for core holdings. Management then waived $3.2 million of incentive fees, boosting net investment income by a penny per share to maintain the dividend intact. I appreciate that shareholder-minded step, but it also points to a thinner earnings cushion if base rates drift lower. BSD Analysis: OSCL is the BDC you want when credit markets get weird — disciplined underwriting, a conservative balance sheet, and the backing of a credit shop that's built to thrive on volatility. Rising rates have juiced net interest income, and credit quality has held up far better than the market expected. Oaktree's origination pipeline remains strong in private credit, where banks are pulling back and spreads are attractive. The company's portfolio is shifting toward more secure, first-lien deals with superior recovery profiles. At its current discount, investors are getting paid handsomely for a risk profile that's far cleaner than the BDC average. This is one of the most professional setups in a sector full of tourists.” | BULL | Q2 2025 Jul 1, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
